Man Group PLC Albireo Pharma, Inc. Transaction History

Man Group PLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$23.94 - $33.74 $547,962 - $772,274	-22,889 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$21.19 - $31.29 $18,392 - $27,159	-868 Reduced 3.65%	22,889 $533,000
Q3 2021 Nov 15, 2021	BUY	$27.36 - $35.98 $45,773 - $60,194	1,673 Added 7.58%	23,757 $741,000
Q2 2021 Aug 16, 2021	SELL	$28.9 - $36.87 $143,893 - $183,575	-4,979 Reduced 18.4%	22,084 $777,000
Q1 2021 May 17, 2021	BUY	$32.03 - $42.85 $1,121 - $1,499	35 Added 0.13%	27,063 $954,000

Q4 2020 Feb 16, 2021	BUY	$31.56 - $42.16 $275,361 - $367,845	8,725 Added 47.67%	27,028 $1.01 Million
Q3 2020 Nov 16, 2020	BUY	$23.19 - $41.61 $20,059 - $35,992	865 Added 4.96%	18,303 $611,000
Q2 2020 Aug 14, 2020	BUY	$14.82 - $29.92 $258,431 - $521,744	17,438 New	17,438 $462,000
Q1 2020 May 15, 2020	SELL	$11.67 - $27.23 $1.1 Million - $2.56 Million	-94,187 Closed	0 $0
Q4 2019 Feb 18, 2020	SELL	$16.92 - $28.96 $1.67 Million - $2.86 Million	-98,663 Reduced 51.16%	94,187 $2.39 Million
Q3 2019 Nov 14, 2019	BUY	$20.0 - $31.88 $67,000 - $106,798	3,350 Added 1.77%	192,850 $3.86 Million
Q2 2019 Aug 14, 2019	BUY	$30.67 - $37.86 $5.14 Million - $6.35 Million	167,729 Added 770.42%	189,500 $6.11 Million
Q1 2019 May 15, 2019	BUY	$22.22 - $32.21 $483,751 - $701,243	21,771 New	21,771 $701,000

865

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.